Neurocrine Biosciences, Inc. (NBIX) Insider Trading
Over the last 3 months, NBIX insiders made 0 open-market buys and 12 sales, a net sale of -$51.0M (SEC Form 4). Over the last 6 months, 613 institutions increased and 446 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
12
Net (3m)
-$51.0M
Insider trades by month Buys Sells
Aug
Nov
Dec
Jan
May
Jun
Context3-month price +23.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Option | 24,965 | $81.49 |
| Jun 4, 2026 | Keswani Sanjay Chandruofficer: Chief Medical Officer | Option | 3,212 | — |
| Jun 4, 2026 | Keswani Sanjay Chandruofficer: Chief Medical Officer | Tax | 1,733 | $154.84 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 14,214 | $154.83 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 9,521 | $157.62 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 5,466 | $155.46 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 3,520 | $158.59 |
| Jun 4, 2026 | Cooke Julieofficer: Chief Human Resources Officer | Sell | 4,216 | $156.77 |
| Jun 2, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Sell | 2,261 | $156.71 |
| Jun 2, 2026 | Onyia Judeofficer: Chief Scientific Officer | Option | 11,000 | $84.74 |
| Jun 2, 2026 | Onyia Judeofficer: Chief Scientific Officer | Sell | 11,000 | $160.25 |
| Jun 2, 2026 | Delaet Ingridofficer: Chief Regulatory Officer | Option | 2,261 | $79.02 |
| May 29, 2026 | Norwalk Leslie Vdirector | Grant | 1,284 | — |
| May 29, 2026 | LYONS GARY Adirector | Grant | 2,624 | $155.83 |
| May 29, 2026 | SHERWIN STEPHEN Adirector | Grant | 2,567 | — |
| May 29, 2026 | Sharp Shalinidirector | Grant | 2,567 | — |
| May 29, 2026 | Mercier Johannadirector | Grant | 2,567 | — |
| May 29, 2026 | Onyia Judeofficer: Chief Scientific Officer | Sell | 11,000 | $155.53 |
| May 29, 2026 | POON CHRISTINE Adirector | Grant | 2,567 | — |
| May 29, 2026 | Norwalk Leslie Vdirector | Grant | 2,624 | $155.83 |
| May 29, 2026 | POPS RICHARD Fdirector | Grant | 2,567 | — |
| May 29, 2026 | MORROW GEORGE Jdirector | Grant | 2,567 | — |
| May 29, 2026 | Onyia Judeofficer: Chief Scientific Officer | Option | 11,000 | $84.74 |
| May 29, 2026 | LYONS GARY Adirector | Grant | 1,284 | — |
| May 29, 2026 | RASTETTER WILLIAM Hdirector | Grant | 2,567 | — |
| May 29, 2026 | GORMAN KEVIN CHARLESdirector | Grant | 5,248 | $155.83 |
| May 28, 2026 | Boyer David W.officer: Chief Corp. Affairs Officer | Sell | 3,888 | $156.64 |
| May 21, 2026 | Mercier Johannadirector | Option | 3,318 | — |
| May 21, 2026 | GORMAN KEVIN CHARLESdirector | Option | 205,088 | $43.24 |
| May 21, 2026 | Norwalk Leslie Vdirector | Option | 1,659 | — |
Source: NBIX SEC Form 4 filings, latest Jun 4, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NBIX positions over the last 6 months (SEC Form 13F).
Increased
613
New positions
212
Reduced
446
Sold out
150
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 13.4M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 12.8M | Feb 12, 2026 |
| VANGUARD GROUP INC | Reduced | 9.7M | Jan 29, 2026 |
| DODGE & COX | Reduced | 5.5M | Feb 13, 2026 |
| DODGE & COX | Reduced | 5.5M | May 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 5.4M | May 13, 2026 |
| JPMORGAN CHASE & CO | Increased | 5.2M | Feb 11, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 4.9M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.7M | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.4M | May 15, 2026 |
| STATE STREET CORP | Reduced | 4.2M | Feb 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3.3M | Feb 17, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3.1M | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 2.4M | May 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.